Haemonetics Corp., one of the oldest medical device firms in Massachusetts, is paying $160 million upfront to acquire Attune Medical, a Chiago-based medtech firm.
Image courtesy Haemonetics Corp
Check out some of the March merger and acquisition activity in Boston-area tech and life sciences, courtesy of reporting by BostInno and the Boston Business Journal.
Be sure to sign up for The Beat, BostInno’s free daily innovation newsletter, so you never miss an M&A deal.
- Boston-based Akari Therapeutics and California’s Peak Bio Inc. agreed to merge as equals. The deal is expected to close late in the second quarter.
- Fusion Pharmaceuticals, a Boston- and Canada-based biotech, is being acquired by AstraZeneca.
- Novartis is shelling out millions to acquire a subsidiary of Boston-based IFM Therapeutics, IFM Due.
- Haemonetics Corp., one of the oldest medical device firms in Massachusetts, is paying $160 million upfront to acquire Attune Medical, a Chiago-based medtech firm.
- Boston-based e-commerce aggregator Perch was acquired by German Razor Group. Subsequently, Perch said it would be laying off 94 employees in four stages.
- Boston-based Linus Health, a digital health company focused on the early detection of dementias, has acquired Aural Analytics. The acquisition of the speech analytics firm will add to Linus Health's detection platform.
- Invicro in Boston and Calyx in London are merging. The combination will increase their digital imaging offerings to the clinical research field.
- SQZ Biotechnologies laid off most of its remaining employees in November, and in March sold off “substantially all assets” to Stemcell Technologies, Canada’s largest biotechnology company.
Sign up for The Beat, BostInno’s free daily innovation newsletter. See past examples here.
